Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis

In Expanded Access, treating physicians are the Sponsor.

Expanded Access requests from treating physicians may be submitted at www.pfizercares.com ; availability will depend on location/country.

Must have severe uncontrolled atopic dermatitis refractory to other available treatments